ArticleJAMA2004
Postmarketing surveillance--lack of vigilance, lack of trust.
Article in JAMA, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Quality of Reporting on the Evaluation of Risk Minimization Programs: A Systematic Review.Drug safety · 2020Pooled it
- Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.BMC medicine · 2016Pooled it
- Safety of medical interventions in children versus adults.Pediatrics · 2014Pooled it
- Trends in adverse reactions to trimethoprim-sulfamethoxazole.Pediatrics · 2013Trial
- Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal.Drug safety · 2008Trial
- Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.Lancet (London, England) · 2022Review
- Assuring long-term safety of highly effective gene-modulating therapeutics for rare diseases.The Journal of clinical investigation · 2021Article
- Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA's Adverse Event Reporting System.Drug safety · 2018Article
- Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network.Oncotarget · 2017Article
- Carboplatin-induced hematotoxicity among patients with non-small cell lung cancer: Analysis on clinical adverse events and drug-gene interactions.Oncotarget · 2017Article
- Pharmacovigilance: pharmacists' perspective on spontaneous adverse drug reaction reporting.Integrated pharmacy research & practice · 2017Review
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases.Oncotarget · 2016Article
- Cardiovascular and pulmonary adverse events in patients treated with BCR-ABL inhibitors: Data from the FDA Adverse Event Reporting System.American journal of hematology · 2015Article
- Real-world analysis of the Celgene Global Drug Safety database: early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash.Therapeutics and clinical risk management · 2015Article
- Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) project.Journal of oncology practice · 2013Article
- A randomized study of how physicians interpret research funding disclosures.The New England journal of medicine · 2012Article
- A pharmacoepidemiological network model for drug safety surveillance: statins and rhabdomyolysis.Drug safety · 2012Article
- A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class.PloS one · 2012Article
- Key concepts of clinical trials: a narrative review.Postgraduate medicine · 2011Review
- Electronic nicotine delivery systems: a research agenda.Tobacco control · 2011Article
Corrections and comments
- Comment on
- Comment on
- Comment on
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
15572723What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.